Binding to RNA is not enough—changing its shape is what makes a drug work, study reveals

Binding to RNA is not enough—changing its shape is what makes a drug work, study reveals

Ribonucleic acids (RNAs) serve as messengers between DNA and protein production, and perform a wide variety of regulatory functions across different cellular processes. This makes them an interesting target for drug designers. Molecular genetics researcher Danny Incarnato (University of Groningen) studies how small-molecule drugs could interfere with RNA structure and function. In a new paper published on March 23 in the journal Nature Communica…